Rituximab improves chances for kidney transplant (Reuters)

[riky]

Rituximab improves chances for kidney transplant
    (Reuters)

 


Reuters - Genentech's cancer drug rituximab,
combined with infusions of antibodies, greatly reduces the risk
that a transplanted kidney will be rejected and vastly improves
the chances of patients finding a donor, researchers reported
on Wednesday.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20080716/hl_nm/transplants_rituxan_dc